Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...
MedPage Today on MSN
T-Cell Killer Opens New Approach to Rheumatoid Arthritis
An investigational monoclonal antibody drug targeting the PD-1 ligand on T cells was a winner in a phase II rheumatoid ...
Morning Overview on MSN
Stem cell breakthrough may restore hearing loss
Recent advancements in stem cell therapy are paving the way for potential breakthroughs in reversing hearing loss. This ...
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.
Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...
CHICAGO — A novel cellular approach that recruits three separate pathways involved in the oncogenesis of Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer, is leading to ...
7d
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback